All results

2 results

• INHALE

  INHALE-1 is a Phase 3, open-label, randomized clinical study evaluating the efficacy and safety of Afrezza in combination with a basal insulin (i.e., the…

  Ages

  4 Years - 17 Years

  Sexes

  All

• Solid - SGT - 001

  This is a controlled, open-label, single-ascending dose study to evaluate the safety, tolerability and efficacy of SGT-001 in adolescents and children with…

  Ages

  4 Years - 17 Years

  Sexes

  Male